DE2515146A1 - Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel - Google Patents

Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Info

Publication number
DE2515146A1
DE2515146A1 DE19752515146 DE2515146A DE2515146A1 DE 2515146 A1 DE2515146 A1 DE 2515146A1 DE 19752515146 DE19752515146 DE 19752515146 DE 2515146 A DE2515146 A DE 2515146A DE 2515146 A1 DE2515146 A1 DE 2515146A1
Authority
DE
Germany
Prior art keywords
bis
mol
acid
found
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752515146
Other languages
German (de)
English (en)
Inventor
Siegfried Dr Linke
Ruediger Dr Sitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE19752515146 priority Critical patent/DE2515146A1/de
Priority to SE7602707A priority patent/SE7602707L/xx
Priority to NO761050A priority patent/NO761050L/no
Priority to IL49352A priority patent/IL49352A0/xx
Priority to AU12714/76A priority patent/AU1271476A/en
Priority to LU74709A priority patent/LU74709A1/xx
Priority to FI760919A priority patent/FI760919A/fi
Priority to NL7603594A priority patent/NL7603594A/xx
Priority to PT64980A priority patent/PT64980B/pt
Priority to BE165915A priority patent/BE840469A/fr
Priority to DK164176A priority patent/DK164176A/da
Priority to ZA762088A priority patent/ZA762088B/xx
Priority to JP51038348A priority patent/JPS51127002A/ja
Priority to FR7610309A priority patent/FR2306683A1/fr
Publication of DE2515146A1 publication Critical patent/DE2515146A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19752515146 1975-04-08 1975-04-08 Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel Pending DE2515146A1 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE19752515146 DE2515146A1 (de) 1975-04-08 1975-04-08 Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
SE7602707A SE7602707L (sv) 1975-04-08 1976-02-27 Karbonsyraamider, sett att framstella dessa och deras anvendning som lekemedel
NO761050A NO761050L (fr) 1975-04-08 1976-03-25
IL49352A IL49352A0 (en) 1975-04-08 1976-04-05 New carboxylic acid amides,their preparation and pharmaceutical compositions containing them
AU12714/76A AU1271476A (en) 1975-04-08 1976-04-06 Carboxylic acid amides
LU74709A LU74709A1 (fr) 1975-04-08 1976-04-06
FI760919A FI760919A (fr) 1975-04-08 1976-04-06
NL7603594A NL7603594A (nl) 1975-04-08 1976-04-06 Werkwijze voor het bereiden van carbonzuuramiden, alsmede de toepassing daarvan als farmaceutische preparaten.
PT64980A PT64980B (en) 1975-04-08 1976-04-06 Process for preparing carboxylic acid amides with hypolipaemic effect application of the same for preparing pharmaceutical compositions with hypolipaemic effect and application of said pharmaceutical compositions for the treatment of hyperlipaemia
BE165915A BE840469A (fr) 1975-04-08 1976-04-07 Nouveaux amides d'acides carboxyliques, leur procede de preparation etmedicament les contenant
DK164176A DK164176A (da) 1975-04-08 1976-04-07 Carboxylsyreamider, fremgangsmade til deres fremstilling samt deres anvendelse som legemidler
ZA762088A ZA762088B (en) 1975-04-08 1976-04-07 Carboxylic acid amides a process for their preparation and their use as medicaments
JP51038348A JPS51127002A (en) 1975-04-08 1976-04-07 Carboxylic amide preparation method thereof and pharmaceutical composition and medicine containing same
FR7610309A FR2306683A1 (fr) 1975-04-08 1976-04-08 Nouveaux amides d'acides carboxyliques, leur procede de preparation et medicament les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752515146 DE2515146A1 (de) 1975-04-08 1975-04-08 Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DE2515146A1 true DE2515146A1 (de) 1976-10-21

Family

ID=5943262

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752515146 Pending DE2515146A1 (de) 1975-04-08 1975-04-08 Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Country Status (3)

Country Link
BE (1) BE840469A (fr)
DE (1) DE2515146A1 (fr)
ZA (1) ZA762088B (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390434A1 (fr) * 1976-06-29 1978-12-08 Rech Applications Therap Composes de depart pour la preparation de derives d'acide penicillanique
EP0345038A2 (fr) * 1988-06-02 1989-12-06 Norsk Hydro A/S Analogues non bêta-oxydables des acides gras ayant pour effet de baisser la concentration hématique du cholesterol et des triglycérides chez les mammifères
EP0411616A1 (fr) * 1989-08-02 1991-02-06 Warner-Lambert Company 4-(amino N-substitué)-2-butynyl-1-carbamates et thiocarbamates et leurs dérivés à titre d'agents muscariniques à action centrale
EP0693466A1 (fr) * 1994-07-22 1996-01-24 Bayer Ag Procédé pour la préparation de composés aromatiques fluorés et diamides
EP1238654A2 (fr) * 2001-03-06 2002-09-11 Kao Corporation Composition pour application externe contenant une diamide
EP1497257A1 (fr) * 2002-04-12 2005-01-19 Alma Mater Studiorum -Universita' di Bologna Derives de benzoquinone 2,5-bis-diamine- 1,4], utiles pour le traitement de la maladie d'alzheimer, leurs procedes de preparation et intermediaires utilises dans ledit procede
WO2006053783A1 (fr) * 2004-11-19 2006-05-26 Glaxo Group Limited Amides et peptides dérivés de tétraalkylènepentamines et leur utilisation en tant qu’agents de transfection
WO2012119781A2 (fr) * 2011-03-10 2012-09-13 University Of Geneva Nouveaux lipides, phospholipides, compositions de phospholipides et de lipides et leur utilisation
WO2023114943A3 (fr) * 2021-12-16 2023-08-03 Acuitas Therapeutics, Inc. Lipides destinés à être utilisés dans des formulations de nanoparticules lipidiques

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390434A1 (fr) * 1976-06-29 1978-12-08 Rech Applications Therap Composes de depart pour la preparation de derives d'acide penicillanique
EP0345038A2 (fr) * 1988-06-02 1989-12-06 Norsk Hydro A/S Analogues non bêta-oxydables des acides gras ayant pour effet de baisser la concentration hématique du cholesterol et des triglycérides chez les mammifères
EP0345038A3 (fr) * 1988-06-02 1991-06-12 Norsk Hydro A/S Analogues non bêta-oxydables des acides gras ayant pour effet de baisser la concentration hématique du cholesterol et des triglycérides chez les mammifères
EP0411616A1 (fr) * 1989-08-02 1991-02-06 Warner-Lambert Company 4-(amino N-substitué)-2-butynyl-1-carbamates et thiocarbamates et leurs dérivés à titre d'agents muscariniques à action centrale
EP0693466A1 (fr) * 1994-07-22 1996-01-24 Bayer Ag Procédé pour la préparation de composés aromatiques fluorés et diamides
US5672765A (en) * 1994-07-22 1997-09-30 Bayer Aktiengesellschaft Process for the preparation of aromatic fluorinated compounds and novel diamides
US7087646B2 (en) 2001-03-06 2006-08-08 Kao Corporation Composition for external application
US7528171B2 (en) 2001-03-06 2009-05-05 Kao Corporation Composition for external application
US7550135B2 (en) 2001-03-06 2009-06-23 Kao Corporation Composition for external application
EP1238654A3 (fr) * 2001-03-06 2004-01-14 Kao Corporation Composition pour application externe contenant une diamide
EP1238654A2 (fr) * 2001-03-06 2002-09-11 Kao Corporation Composition pour application externe contenant une diamide
EP1803439A3 (fr) * 2001-03-06 2008-06-11 Kao Corporation Composition pour application externe contenant un diamide
EP1497257A1 (fr) * 2002-04-12 2005-01-19 Alma Mater Studiorum -Universita' di Bologna Derives de benzoquinone 2,5-bis-diamine- 1,4], utiles pour le traitement de la maladie d'alzheimer, leurs procedes de preparation et intermediaires utilises dans ledit procede
JP2008520610A (ja) * 2004-11-19 2008-06-19 グラクソ グループ リミテッド トランスフェクション剤としてのテトラアルキレンペンタミンのアミドおよびペプチド誘導体
WO2006053783A1 (fr) * 2004-11-19 2006-05-26 Glaxo Group Limited Amides et peptides dérivés de tétraalkylènepentamines et leur utilisation en tant qu’agents de transfection
US7772413B2 (en) 2004-11-19 2010-08-10 Glaxo Group Limited Amide and peptide derivatives of tetraalkylenepentamines as transfection agents
WO2012119781A2 (fr) * 2011-03-10 2012-09-13 University Of Geneva Nouveaux lipides, phospholipides, compositions de phospholipides et de lipides et leur utilisation
WO2012119780A3 (fr) * 2011-03-10 2012-12-20 University Of Geneva Nouveaux lipides et nouvelles structures phospholipidiques
WO2012119781A3 (fr) * 2011-03-10 2013-01-03 University Of Geneva Nouveaux lipides, phospholipides, compositions de phospholipides et de lipides et leur utilisation
WO2023114943A3 (fr) * 2021-12-16 2023-08-03 Acuitas Therapeutics, Inc. Lipides destinés à être utilisés dans des formulations de nanoparticules lipidiques

Also Published As

Publication number Publication date
ZA762088B (en) 1977-04-27
BE840469A (fr) 1976-10-07

Similar Documents

Publication Publication Date Title
DE69409525T2 (de) Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung
DE69210067T2 (de) Hydraxamsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE1595915C3 (de) Pyrrolidinderivate
DE60014588T2 (de) Thioamidderivate
DE3885889T2 (de) (r)5-pentylamino-5-oxopentanesäure-derivate mit anticholecystokininwirkung.
DE69734773T2 (de) Nicht-peptidische Bombesin-Rezeptor-Antagonisten
DE69809782T2 (de) Npy antagonisten
DE4102024A1 (de) Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0505868A2 (fr) Dérivés des acides N-acyl-alphaaminés
DE2856753A1 (de) N-substituierte omega -aminoalkanoyl- omega -aminoalkansaeuren, ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
CH678621A5 (fr)
DE2515146A1 (de) Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CH623024A5 (en) Process for the preparation of 1-aryloxy-3-N-(substituted)aminopropanes
DE69102352T2 (de) N-Benzyl-N1-phenyl und -phenalkyl-thioharnstoffe.
DE2737738C2 (de) 3-Amino-thiophen-4-carbonsäuren und deren Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
DE69012040T2 (de) Benzanilidederivate und Ihre Verwendung als anti-atherosclerosis Wirkstoffe.
NO761050L (fr)
DE2903615A1 (de) Guajakacylester von mercaptopropionsaeurederivaten, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE2362754A1 (de) Cyclopropylmethylamine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE2551483A1 (de) Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE69713128T2 (de) 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen
DE3111025C2 (fr)
DE68924416T2 (de) Carboximidamid-Derivate.
DE69015208T2 (de) Glutamin- und asparginsäurederivate mit antigastrinwirkung und verfahren zu deren herstellung.
DE3887611T2 (de) Butensäure-Amide, deren Salze, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.

Legal Events

Date Code Title Description
OHN Withdrawal